Combination Chemotherapy in Treating Patients With Recurrent, Refractory, or Metastatic Solid Tumors or Lymphomas

ABSTRACT: RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase I trial to study the effectiveness of combining gemcitabine, fluorouracil, and leucovorin in treating patients with recurrent, refractory, or metastatic solid tumors or lymphomas.

DISEASE(S): Lung Cancer,Colorectal Cancer,Liver Cancer,Small Intestine Cancer,Pancreatic Cancer,Gallbladder Cancer,Liver Neoplasms,Extrahepatic Bile Duct Cancer,Lymphoma,Lung Neoplasms,Unspecified Adult Solid Tumor, Protocol Specific,Esophageal Neoplasms,Gallbladder Neoplasms,Bile Duct Neoplasms,Esophageal Cancer,Pancreatic Neoplasms,Intestinal Neoplasms,Cholangiocarcinoma

PROVIDER: 2006400 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR